Development of new therapy for uterine cervical carcinoma

宫颈癌新疗法的开发

基本信息

  • 批准号:
    08557092
  • 负责人:
  • 金额:
    $ 5.76万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

1. Alterations in cell morphology induced by HPV16E7 We have shown that SM-alpha actin transcription and translation are completely inhibited in the presence of HPV16E7 protein expressed in Rat embryonal fibroblasts. To explore the mechanism involved in the transcriptional silencing of SM-alpha actin, we have made the C24G (Sub-stitution of codon 24 glycine for cystein) and the C91G mutant E7 protein as Rb-and C-jun binding domains are important for E7-mediated cell transformation. A Wild-type E7 and C24G mutant had a potential to inhibit SM-alpha actin transcription. In turn, aC91G mutant abrogated its function to silence the SM- alpha transcription, suggesting the importnatce of c-ter region of E7. In addition, suppression of MyoD expression by wild-type and 024G mutants were in contrast to the absent of MyoD suppression by 091 G.These suggested that modulation of MyoD expression by E7 and E7-c-jun binding are important for the SM-alpha actin silencing in the HPV16E7 expressing cells … More .2. Molecular diagnosis of cervical cell carcinoma progression We have amplified HPV E6/E7 DNAs obtained from lymph nodes of 64 patients by the use of consensus primers targeted to the E6/E7 and amplified DNAs were subjected to southern blot analyses. Histo-pathological examinations indicated the positive lymph node metastasis in 10 out of 64 patients. However, the PCR-southern blot examination showed the presence of HPV16 E6/E7 DNAs in the lymph nodes from 45 patients out of the remaining lymph node metastasis negative 54 patients. These suggested the sensitivity of PCR-Southern methods to detect lymph node metastasis.3. Development of antisense oligo nucleotides (AS) with enhanced functions. We have developed the psolaren-conjugated AS that is targeted to HPV16 or 18 E6 (PS-P1, PS-K3 and PS-K4). A scramble PS-1scr was used as a control. In the presence of UV irradiation, PS-Pi suppressed the growth of cervical cancer cells, that was dependent on the E6 gene sequence. C4 II cervical cancer cells maybe encoded the endogenous mRNA targeted by both PS-K3 and PS-K4. PS-AS had aAS potential to inhibit the cancer cell growth, that was more than 80 folds, compared to phospborothioate AS.PS-AS did not exhibit the toxic effects to normal keratinocyte growth. Less
1. HPV 16 E7诱导的细胞形态学改变我们已经证明,在大鼠胚胎成纤维细胞中表达的HPV 16 E7蛋白存在时,SM-α肌动蛋白的转录和翻译被完全抑制。为了探索SM-α肌动蛋白转录沉默的机制,我们将C24 G(24号密码子甘氨酸取代半胱氨酸)和C91 G突变体E7蛋白作为Rb和C-jun结合结构域,对E7介导的细胞转化是重要的。野生型E7和C24 G突变体具有抑制SM-α肌动蛋白转录的潜力。而C91 G突变体则使SM-α转录沉默功能丧失,提示E7的c-ter区的重要性。此外,野生型和024 G突变体对MyoD表达的抑制与091 G对MyoD表达的不抑制形成对比。这些表明E7和E7-c-jun结合对MyoD表达的调节对于HPV 16 E7表达细胞中SM-α肌动蛋白沉默是重要的 ...更多信息 .2.宫颈细胞癌进展的分子诊断我们通过使用靶向HPV E6/E7的共有引物扩增从64名患者的淋巴结中获得的HPV E6/E7 DNA,并对扩增的DNA进行Southern印迹分析。64例患者中10例组织病理检查显示淋巴结转移阳性。而在54例淋巴结转移阴性的患者中,45例患者的淋巴结中存在HPV 16 E6/E7 DNA。提示PCR-Southern方法检测淋巴结转移的敏感性.具有增强功能的反义寡核苷酸的开发。我们已经开发了靶向HPV 16或18 E6的psolaren缀合的AS(PS-P1、PS-K3和PS-K4)。使用加扰PS-1 scr作为对照。在紫外线照射的情况下,PS-Pi抑制宫颈癌细胞的生长,这依赖于E6基因序列。C4 Ⅱ宫颈癌细胞可能编码PS-K3和PS-K4共同靶向的内源性mRNA。PS-AS对癌细胞生长的抑制作用是硫代磷酸AS的80倍以上,对正常角质形成细胞的生长无毒性作用。少

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kato K et al: "Contribution of enhanced transcriptional activation by ER to [12 val] K-Ras mediated NIH3t3 cell transformation."Oncogene. 15. 3037-3046 (1997)
Kato K 等人:“ER 增强转录激活对 [12 val] K-Ras 介导的 NIH3t3 细胞转化的贡献。”癌基因。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kato, K., et al: "Oncogenic Ras modulates epidermal growyt factor responseiveness in endometiral carcinomas." European J.Cancer. 34. 5,737-744 (1998)
Kato, K. 等人:“致癌 Ras 调节子宫内膜癌中表皮生长因子的反应性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kato.K.,et al: "Oncogenic Ras modulates epidermal growth factor responsive ness in end ometiral carcinomas" European J.Cancer. 34・5. 737-744 (1998)
Kato.K. 等人:“致癌 Ras 调节子宫内膜癌中的表皮生长因子反应性”European J.Cancer 34·5 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Vojata, PJ., et al: "Evidence for Two Senescence Locion Human Chromosomel" Genes, Chromosomes & Cancer. 16. 55-63 (1996)
Vojata, PJ. 等人:“人类染色体两个衰老位置的证据”基因,染色体
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimizu A,et al: "CyclinG Contributes to G2/M arrest of cells in response to DNA Damage." Biochemical and Biophysical Research Communications. (in press).
Shimizu A 等人:“CyclinG 有助于响应 DNA 损伤而导致细胞 G2/M 期停滞。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WAKE Norio其他文献

Transcriptional factors, DEC1 and DEC2 cooperatively regulate epithelial-to-mesenchymal transition of uterine endometrial cancer cells.
转录因子DEC1和DEC2协同调节子宫内膜癌细胞的上皮间质转化。
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    ASANOMA Kazuo;KOBAYASHI Hiroaki;WAKE Norio;KATO Kiyoko
  • 通讯作者:
    KATO Kiyoko

WAKE Norio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WAKE Norio', 18)}}的其他基金

Genome diversity associated with in montalization and establishment of endometrial cancer stem cell isolation
与子宫内膜癌干细胞分离的蒙塔化和建立相关的基因组多样性
  • 批准号:
    20390435
  • 财政年份:
    2008
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular targeted therapy by inducing cancer cell senesence
通过诱导癌细胞衰老的分子靶向治疗
  • 批准号:
    14104014
  • 财政年份:
    2002
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Molecular mechanism of endometrial carcinoma development and their application for the new molecular target therapy
子宫内膜癌发生的分子机制及其在新型分子靶向治疗中的应用
  • 批准号:
    12470344
  • 财政年份:
    2000
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of cell senescence
细胞衰老的分子机制
  • 批准号:
    11557121
  • 财政年份:
    1999
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of endometrial cancer and its application to gene diagnosis
子宫内膜癌的分子机制及其在基因诊断中的应用
  • 批准号:
    09470362
  • 财政年份:
    1997
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of gene diagnosis and therapy for Endometrial carcinoma.
子宫内膜癌基因诊断和治疗的建立。
  • 批准号:
    07457391
  • 财政年份:
    1995
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic Events Associated With Choriocarcinogenesis.
与绒毛膜癌发生相关的遗传事件。
  • 批准号:
    07042006
  • 财政年份:
    1995
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of gene diagnosis and therapy for endometrial cancers.
子宫内膜癌基因诊断和治疗的发展。
  • 批准号:
    05454453
  • 财政年份:
    1993
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Application of antisense oligo DNA to uterine cancers.
反义寡DNA在子宫癌中的应用。
  • 批准号:
    05557073
  • 财政年份:
    1993
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Genetic events associated with human endometrial carcinogenesis.
与人类子宫内膜癌发生相关的遗传事件。
  • 批准号:
    03454399
  • 财政年份:
    1991
  • 资助金额:
    $ 5.76万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了